stella
beta
Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening — Stella
Home
/
Age-Related Macular Degeneration (AMD)
/
Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening
View on ClinicalTrials.gov
Recruiting
Back to Age-Related Macular Degeneration (AMD) trials
Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
Taiwan
National Taiwan University Hospital, Taipei, Taiwan
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow